We are joined by Dr. Aaron Mansfield of the Mayo Clinic to discuss a new, now enrolling, clinical trial for peritoneal mesothelioma that randomizes patients into two arms: an arm that receives chemotherapy + bevacizumab, and an arm that receives chemotherapy, bevacizumab and immunotherapy.
Watch video MesoTV | NOW ENROLLING: Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma online without registration, duration hours minute second in high quality. This video was added by user Mesothelioma Applied Research Foundation 23 December 2021, don't forget to share it with your friends and acquaintances, it has been viewed on our site 339 once and liked it 2 people.